ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ERIK RIESSEN M.D.

Internal Medicine

6,520

$518K

476
386 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$80
Average prescription price

Avg: $62

REID HALES MD

Internal Medicine

6,491

$430K

430
376 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $62

JEFFREY OGDEN M.D

Internal Medicine

6,465

$529K

322
265 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $62

MALGORZATA HECHT MD

Internal Medicine

6,325

$449K

447
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $62

WALSTIR FONSECA MD

Internal Medicine

6,279

$432K

457
415 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $62

HANADI FARRUKH MD

Internal Medicine

6,245

$393K

303
267 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $62

MICHAEL FRANCIS D.O.

Internal Medicine

6,241

$300K

294
229 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $62

ANNE PENDO MD

Internal Medicine

6,063

$362K

474
432 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $62

JOHN DOANE MD

Internal Medicine

6,052

$392K

352
295 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

ANN RICHARDS MD

Internal Medicine

5,950

$386K

328
297 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

JUNE STEELY MD

Internal Medicine

5,908

$370K

355
316 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $62

BHARANI SRINIVASAN MD

Internal Medicine

5,865

$342K

313
267 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

KENNETH GOLDBERG M.D.

Internal Medicine

5,780

$370K

264
224 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $62

JOHN LURAS MD PC

Internal Medicine

5,766

$365K

306
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $62

THOMAS CAINE MD

Internal Medicine

5,742

$292K

292
247 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

RICHARD HEROLD MD

Internal Medicine

5,737

$310K

311
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

BARBARA RIZZARDI MD

Internal Medicine

5,719

$495K

250
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 23%

$87
Average prescription price

Avg: $62

STEVEN TEMPLE MD

Internal Medicine

5,688

$364K

635
608 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $62

TYLER WILLIAMS M.D.

Internal Medicine

5,649

$351K

430
371 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $62

MARGARET SOLOMON MD

Internal Medicine

5,562

$292K

246
155 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $62

RUSSELL SHIELDS MD

Internal Medicine

5,464

$272K

273
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $62

JUDD LAROWE MD

Internal Medicine

5,423

$350K

454
408 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

DANIEL MONAHAN M.D.

Internal Medicine

5,273

$353K

192
159 are 65+

22%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $62

DARIN CHECKETTS D.O.

Internal Medicine

5,244

$349K

236
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $62

JONATHAN VELLINGA M.D.

Internal Medicine

5,174

$338K

436
386 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank